CellGenTech Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 9

CellGenTech General Information

Description

Developer of a bio-venture company designed to provide therapeutic products. The company is developing processed cellular therapy outcomes using therapeutic genetically modified human adipocytes whereby specific enzymes and functional proteins are replenished through the transplantation of human-derived cells, enabling patients to utilize their adipocytes to treat familial lecithin-cholesterol acyltransferase deficiency.

Contact Information

Website
www.cellgentech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Chiba University Inohana Innovation Plaza 101
  • 1-8-15 Inohana, Chuo-ku
  • Chiba, 260-0856
  • Japan
+81
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Chiba University Inohana Innovation Plaza 101
  • 1-8-15 Inohana, Chuo-ku
  • Chiba, 260-0856
  • Japan
+81

CellGenTech Timeline

2021202220232024
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellGenTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 01-Mar-2023 Completed Generating Revenue
8. Secondary Transaction - Private Completed Generating Revenue
7. Later Stage VC (Series F) 28-Oct-2021 Completed Generating Revenue
6. Accelerator/Incubator 01-Nov-2019 Completed Generating Revenue
5. Later Stage VC (Series E) 29-May-2019 Completed Generating Revenue
4. Later Stage VC (Series E) 31-Aug-2018 Completed Generating Revenue
3. Later Stage VC (Series C) Completed Generating Revenue
2. Early Stage VC (Series B) $3.99M $4.77M Completed Generating Revenue
1. Early Stage VC (Series A) $777K $777K Completed Generating Revenue
To view CellGenTech’s complete valuation and funding history, request access »

CellGenTech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
F Shares
E Shares
D Shares
C Shares
B Shares 4,280 $1062.93 $1062.93 1x $1062.93 16.46%
A Shares 1,250 $708.62 $708.62 1x $708.62 4.81%
To view CellGenTech’s complete cap table history, request access »

CellGenTech Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

CellGenTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-5806791-B2 Method for determining whether a cell population is suitable for introduction of a foreign gene for the preparation of adipocytes for gene therapy Active 21-Jan-2010
JP-WO2011090091-A1 Method for determining whether a cell population is suitable for introduction of a foreign gene for the preparation of adipocytes for gene therapy Active 21-Jan-2010
JP-2009179571-A Agent for reinforcing wound-treating effect of g-csf by external application Pending 29-Jan-2008
JP-2009201518-A Cell for gene therapy of lcat deficiency, and replication-deficient retrovirus vector and plasmid for use in production of the cell Inactive 02-Mar-2007
JP-WO2008108344-A1 Cell therapy cell for lcat deficiency and cell composition for gene therapy Pending 02-Mar-2007 A61K38/45
To view CellGenTech’s complete patent history, request access »

CellGenTech Executive Team (1)

Name Title Board Seat
Masayuki Aso Founder, President & Chief Executive Officer
To view CellGenTech’s complete executive team members history, request access »

CellGenTech Board Members (3)

Name Representing Role Since
Michihiro Oka Self Board Member
Tetsuya Mishima Self Board Member
You’re viewing 2 of 3 board members. Get the full list »

CellGenTech Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
STRIVE (VC Investor) Corporate Venture Capital Minority
Healthcare Innovation Venture Capital Minority
FASTAR Accelerator/Incubator
CareNet Corporation Minority
Medical Incubator Japan Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

CellGenTech FAQs

  • When was CellGenTech founded?

    CellGenTech was founded in 2003.

  • Who is the founder of CellGenTech?

    Masayuki Aso is the founder of CellGenTech.

  • Who is the CEO of CellGenTech?

    Masayuki Aso is the CEO of CellGenTech.

  • Where is CellGenTech headquartered?

    CellGenTech is headquartered in Chiba, Japan.

  • What industry is CellGenTech in?

    CellGenTech’s primary industry is Drug Discovery.

  • Is CellGenTech a private or public company?

    CellGenTech is a Private company.

  • What is CellGenTech’s current revenue?

    The current revenue for CellGenTech is .

  • How much funding has CellGenTech raised over time?

    CellGenTech has raised $22.4M.

  • Who are CellGenTech’s investors?

    STRIVE (VC Investor), Healthcare Innovation, FASTAR, CareNet, and Medical Incubator Japan are 5 of 9 investors who have invested in CellGenTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »